LetterLetter
Maintenance of Low Disease Activity following Tumor Necrosis Factor Inhibitor Dose Tapering in Ankylosing Spondylitis
LAUREN STEEL and KARL GAFFNEY
The Journal of Rheumatology August 2017, 44 (8) 1292; DOI: https://doi.org/10.3899/jrheum.170057
LAUREN STEEL
Rheumatology Department, Norfolk and Norwich University UK National Health Service (NHS) Foundation Trust;
MBBS, BSc, MRCP (London)KARL GAFFNEY
Rheumatology Department, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich,
UK.
MB ChB, BAO (Hons), FEGEMS, FRCPI, FRCPREFERENCES
- 1.↵
- 2.↵
- Závada J,
- Uher M,
- Sisol K,
- Forejtová Š,
- Jarošová K,
- Mann H,
- et al.
- 3.↵
- Plasencia C,
- Kneepkens EL,
- Wolbink G,
- Krieckaert CL,
- Turk S,
- Navarro-Compán V,
- et al.
- 4.↵
- Yates M,
- Hamilton LE,
- Elender F,
- Dean L,
- Doll H,
- MacGregor AJ,
- et al.
In this issue
The Journal of Rheumatology
Vol. 44, Issue 8
1 Aug 2017
Maintenance of Low Disease Activity following Tumor Necrosis Factor Inhibitor Dose Tapering in Ankylosing Spondylitis
LAUREN STEEL, KARL GAFFNEY
The Journal of Rheumatology Aug 2017, 44 (8) 1292; DOI: 10.3899/jrheum.170057